13887: Nadal: Lisit of the Drugs taken by Jean Bertrand Aristide (fwd)

[Bob Corbett <corbetre@webster.edu>]

From: Olivier Nadal <o_nadal@bellsouth.net>

Here is the List of the Drugs taken by Jean Bertrand Aristide. All those who
do not believe that JBA is insane, the daily climate of political violence
and  state terrorism institutionalized by Jean Bertrand Aristide and his
Lavalas Party in 1991 and from 1994 until today ,2002 , should be a proof
for those again who want to listen with honesty  that haitians are living a
nightmare.
Olivier Nadal





LITHIUM OLIGOSOL




Presentation and Conditioning
Box of 14 vials of 2 ml, injectable or sublingual
The administration by the sublingual way is recommended.

Composition
 1 vial  Box of 14 vials
Lithium gluconate   0.0081g  0.1134g
Gluconate isotonic solution given by injection
Glugonate manufacturing procedure patented

Pharmacology
Medication for certain forms of psychotic disorders

Indications
Nervousness. Anxiety. Aggressive and agitated behavior. Mood disorders.
Manifestations of chronic psychosis and of vascular sclerosis in elderly
patients.
Lithium Oligosol is also used in the treatment of acute psychosis with
psychic depression

Dosage
2 to 6 vials a day, depending on the severity of symptoms.
A.M.M.307515.1
Marketed since 1953
Price: F 7.25
Social Security Refund 70%


LABCATAL
7 rue Roger salengro
92120 Montrouge
? 01.47.35.85.30




HALDOL
Vials - Drops - Tablets: 5mg


Presentation
Vials of 1ml I.M or I.V. injections - Box of 5
Drops, oral intake - Bottle of 15 ml
Tablets, oral intake - Box of 30

Composition
Haloperidol ou 4' - fluor-4 [1-4 hydroxy-4-(4' chloro) - phenyl piperidino]
Butyrophenone
Vials 1 vial Box of 14 vials
Haloperidol 5 mg 25 mg
Excipients: lactic acid. Preservatives: methylparaben, propylparaben

Drops
 p. ml  p. bottle
Haloperidol  20 drops
 2 mg 30 mg
Excipients: lactic acid. Preservatives: methylparaben, propylparaben

Tablets
 p. tablet  p. box
Haloperidol  5 mg  150 mg
All tablets are gluten-free, lactose-free and metabisulfite-free.
Preservatives: methylparaben, propylparaben

About the medication
When administered to rats, Haloperidol is quickly absorbed. Peack plasma
levels of ingested radioactive drug (around 15%) occurs in the liver within
3 hours.
Although excretion begins rapidly, in urine and in feces, 1/3 within 24
hours and the rest is excreted within 72 hours.

Properties: Effective Neuroleptic
Haldol - Haloperidol - is a butyropherone derivative with antipsychotic
properties that has been considered very a effective drug.

Indications
In Psychiatry Haloperidol is indicated in the management of the following
cases
? Neuromuscular agitation in general (mania, flush delirium, delirium
tremens)
? Acute psychosis, psychotic agitation
? Chronic hallucination
? Chronic psychosis - chronic delirium and mania. In some cases with adverse
symptoms, and in resistant patients, inceasing dosage adequately can produce
favorable results.

In Anesthesiology: Haldol has weak alpha-adrenolytic and possesses strong
antiemetic properties; may potentiate the action of barbiturates which
explain its interest in anesthesiology or in general anethesics.

Antiemetic properties: very efficient anti-emetic medication (vomiting due
to antimitotic treatmen)

Contraindications
Parkinson's disease, multiple sclerosis, hemiplegia, pregnancy

Precautions
In all cases, it is best to start with weak doses and gradually increase
them.
It is not recommended to use Haldol if you are on a diet.
Although haloperidol is a relatively nonsedating neuroleptic, sedation may
occur in some patients. There is a risk at the beginning of the cure for
those driving and operating dangerous machinery.
Caution is advised with epileptic patients.
Patients must be informed that they should not drink alcohol while taking
Haldol. It may potentiate the effects of alcohol and other psychotropic
drugs; caution should therefore be exercised when it is used with agents of
this type and adjustments in their dosage may be required
If hyperthermia and pallor occur, immediate discontinuation of treatment is
required because a symptom complex sometimes referred to as "Neuroleptic
malignant syndrome" may occur.

Adverse effects
They are common to every major neuroleptic medication. Haldol has a marked
tendency to provoke extrapyramidal effects such as Parkinson-like symptoms.
They are usually related in occurrence when the dose is reduced and / or
when administered an antiparkinson agent and more acute paroxysmal attacks
(involuntary movements of the tongue, face, mouth or jaw) are rare.
As with all antipsychotic agents, tardive dyskinesia may appear in some
patients on long-term therapy.

Dosage
In psychiatry: Initial dosage should be strictly individualized
Adults:
1. Drops 2?: average dosage varies between 1 to 20 mg 2 or 3 times daily (10
to 200 drops)
2. Vials 5?: intravenous, intramuscularly injection
3. Tablets: 5 to 40 mg (1 to 8 tablets) daily
It is important initially to increase dosage adequately until 75 mg and more
if necessary.

Children:
Lower doses are recommended since they may be more sensitive to the drug.
Initial daily doses ranging from 2 to 5 drops a day should be employed.
Upward adjustment of these doses should be made gradually;
? above 5 years: ½ of the adult dose
? 2 - 5 years; ¼ of the adult dose
? under 2 years: exceptional prescription under very strict medical
supervision

In anesthesiology:
Pre-medication: 1/2 or 1 vial, in I.M.
In the anesthesiology solution: intravenous way is preferred.

Overdose
The most common symptom is hypotension caused by antiparkinsonian
medication. Medical surveillance is necessary and the appearance of any
other symptom would require a treatment adjusted to symptoms


VISAS 262.20.242 (Vials.)-262.20.244 (Drops)
Marketed since1960
551.985.3 (Tablets)
Price:  F 9.75 + 0.35 SHP (Vials)
F 6.85 + 0.35 SHP (Drops)
F 21.70 + 0.35 SHP (Tablets)
Social Security Refund 70%
Collect. Art. 115 - AMG - AP
Licence JansesenPharmaceutica.





Laboratoire L BRUN
5, rue de Lübeck
751160PARIS
? 01.47.23.61.62



TRILIFAN 16mg
TRILIFAN 4mg


Supplied
Tablets 16 mg - Box of 15
Tablets  4 mg - Box of 50

Composition
Trilafan 16mg  p. tablet  p. box
Perphenazine  16 mg  240 mg

Trilafan 4mg p. tablet p. box
Perphenazine  4 mg  200 mg
Excipients: lactose, corn starch, gelatin, magnesium stearate, talc,
sucrose, terra alba, carnauba wax, dye: Opalux Gray, white wax.

Pharmacology
Trilafan is quickly excreted by the body in urine and in feces.
For the same dose of phenotiazine administered, patients blood count varies
greatly from one to the other and adverse effects on the nervous system are
not fully known.

Properties
Perphenazine is a neuroleptic drug of the phenotiazines piperazines group.
It is mainly used for tis antipsychotic action.
Administered in small doses, it is used for its antiolyptic and antiemetic
properties. It can also be used as a sedative in patients suffering from
behavioral complications (agitation, aggression).

Indications
Trilafan 16 mg
? Therapeutic relay drug in acute psychosis following treatment with similar
medication
? Chronic psychosis, psychic disorders, agitated behavior in patients with
mental retardation, anxiety, aggressiveness, agitation and other behavioral
disorders

Trilafan 4 mg
? Agitated behavior, hypochondria
? Child psychosis
? Psychic disorders

Contraindications
? Hyperthermia in some patients with know history of hyperthermia to
neuroleptic drug
? Hypersensitivity due to the presence phenothiazines
? Serious hepatic, renal, cardiovascular and respiratory insufficiencies are
suspected
? Porphyria

Perphenazine should not be used in pregnant women because the drug is
excreted in breast milk very rapidly.

Warning
There is no risk of becoming neuroleptic-dependant. Very rarely, patient can
develop neuroleptic malignant syndrome (manifestations are hyperthermia and
pallor) or sudden death (occurs in patients with movement disorders).

Precautions
Particular care must be paid to extrapyramidal symptoms; neuroleptics
(antipsychotic) drugs may provoke signs of tardive dyskinesia or Parkinson's
syndrome. Treatment exists for those complications (and they can be
eventually prevented) by administering an antiparkinsonian medication.
There is a risk at the beginning that perphenazine may impair physical
abilities (sleepiness) fo those driving a car or operating machinery.
Epileptic patients receiving perphenazine should be kept under close
supervision
The use of alcohol and other sedatives in general (hypnotic, anesthetics,
tranquilizers) is strictly prohibited. Possible interactions with
medications administered for hypertension may result in additive
hypotension.
During prolonged therapy, blood counts should be checked periodically,

Adverse effects
The use of antipsychotic phenothiasinic neuroleptics may cause
? Extrapyramidal manifestations and drowsiness (frequent with this type of
medication)
? Vapopressors may be used to treat hypotesion
? Endocrine or metabolic complications may occur: gain weight, ameorrhea,
changes in libido (temporary)
? May occur: dry mouth, constipation, blurred vision, urinary retention

Dosage
Must be individualized and adjusted according to the patient.
? Trilifan16 mg: treatment of disturbed chronic psychosis and psychiatric
disorders - dose must adjusted between 1 - 4 tables daily
? Trilifan 4mg:
Adults with psychotic manifestations: average dose is 1 tablet three times a
day
Children with psychosis or other disorders: 1 - 8 tablets daily taken at 3
different times

Overdose
A coma may occur in patients with severe neuroleptic phenothiazic overdose
(including tremor, muscle twitching, spasm). In more severe intoxication,
symptoms include hypotension, respiratory and a risk of vasomotor collapse,
hypothermia.
Patient should be hospitalized as soon as possible. Emergency treatment
should start immediately.


VISAS NL 2976 (16 mg) - NL 168 (4 mg)
Marketed sine 1962
Price:  F 8.40 + S.H.P. (16 mg)
 F 8.10 + S.H.P. (4 mg)
Social Security Refund 70%  - Collect.
In Psychiatric Hospitals




Laboratoire CETRANE
Filiale de SCHERING CORPORATION USA
92 rue Baudin
92307 LEVALLOIS-PERRET
? 01.47.39.94.80